Identification of the novel FOXP3-dependent Treg cell transcription factor MEOX1 by high-dimensional analysis of human CD4+ T cells
CD4 + T cells play a central role in the adaptive immune response through their capacity to activate, support and control other immune cells. Although these cells have become the focus of intense research, a comprehensive understanding of the underlying regulatory networks that orchestrate CD4 + T c...
Gespeichert in:
Veröffentlicht in: | Frontiers in immunology 2023-07, Vol.14, p.1107397-1107397 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | CD4
+
T cells play a central role in the adaptive immune response through their capacity to activate, support and control other immune cells. Although these cells have become the focus of intense research, a comprehensive understanding of the underlying regulatory networks that orchestrate CD4
+
T cell function and activation is still incomplete. Here, we analyzed a large transcriptomic dataset consisting of 48 different human CD4
+
T cell conditions. By performing reverse network engineering, we identified six common denominators of CD4
+
T cell functionality (CREB1, E2F3, AHR, STAT1, NFAT5 and NFATC3). Moreover, we also analyzed condition-specific genes which led us to the identification of the transcription factor MEOX1 in T
reg
cells. Expression of MEOX1 was comparable to FOXP3 in T
reg
cells and can be upregulated by IL-2. Epigenetic analyses revealed a permissive epigenetic landscape for MEOX1 solely in T
reg
cells. Knockdown of MEOX1 in T
reg
cells revealed a profound impact on downstream gene expression programs and T
reg
cell suppressive capacity. These findings in the context of CD4
+
T cells contribute to a better understanding of the transcriptional networks and biological mechanisms controlling CD4
+
T cell functionality, which opens new avenues for future therapeutic strategies. |
---|---|
ISSN: | 1664-3224 1664-3224 |
DOI: | 10.3389/fimmu.2023.1107397 |